23465-76-1CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21MSPRUJDUTKRMLM-UHFFFAOYSA-NCaroverine is a quinoxaline derivative.
23465-76-1DTXSID6049010Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
UsesCaroverine is a quinoxaline compound that was originally developed as a spasmolytic drug, but is now used to treat inner ear diseases such as tinnitus. Caroverine is a calcium channel blocker and is also an antiglutamatergic drug.
No reaction records under the current filter.
Loading…
CHEMBL1729803CHEBI:135541DefinitionChEBI: Caroverine is a quinoxaline derivative.